M. E. Gore
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
-
- Ovarian cancer diagnosis and treatment 17
- Oncology 23
- Cutaneous Melanoma Detection and Management 5
- Cancer Treatment and Pharmacology 5
- Co-authors
- Roger A’Hern (8 shared papers)Jonathan L. Moore (4 shared papers)Timothy John Perren (6 shared papers)Raymond Despax (1 shared paper)G. Favalli (1 shared paper)Giovanna Scarfone (1 shared paper)Jaap Verweij (1 shared paper)Wim W. ten Bokkel Huinink (1 shared paper)
- Journals
- British Journal of Cancer (19 papers)Annals of Oncology (12 papers)European Journal of Cancer (8 papers)Journal of Clinical Oncology (5 papers)The Lancet (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
M. E. Gore
65 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 108
- Reproductive Medicine 474
- Oncology 802
- Obstetrics and Gynecology 170
- Otorhinolaryngology 66
- Pathology and Forensic Medicine 252
Countries citing papers authored by M. E. Gore
This map shows the geographic impact of M. E. Gore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Gore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Gore more than expected).
Fields of papers citing papers by M. E. Gore
This network shows the impact of papers produced by M. E. Gore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Gore. The network helps show where M. E. Gore may publish in the future.
Co-authors
The 25 scholars most cited alongside M. E. Gore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 350 | |
| 2 | 1996 | 99 | |
| 3 | EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. | 2008 | 96 |
| 4 | 1996 | 90 | |
| 5 | 1987 | 89 | |
| 6 | 2013 | 75 | |
| 7 | 1999 | 72 | |
| 8 | 1990 | 69 | |
| 9 | 1995 | 63 | |
| 10 | 1987 | 61 | |
| 11 | 1998 | 60 | |
| 12 | 2009 | 58 | |
| 13 | 1997 | 57 | |
| 14 | 1995 | 56 | |
| 15 | 1990 | 55 | |
| 16 | 1997 | 52 | |
| 17 | 1995 | 49 | |
| 18 | 1996 | 48 | |
| 19 | 1989 | 48 | |
| 20 | 1990 | 48 |
About M. E. Gore
M. E. Gore is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Pathology and Forensic Medicine and Cancer Research, having authored 65 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (17 papers), Renal cell carcinoma treatment (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Endometrial and Cervical Cancer Treatments (6 papers), Cutaneous Melanoma Detection and Management (5 papers), Cancer Treatment and Pharmacology (5 papers), Melanoma and MAPK Pathways (5 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). The work is most often cited by research in Reproductive Medicine (474 citations), Oncology (802 citations), Obstetrics and Gynecology (170 citations), Otorhinolaryngology (66 citations) and Pathology and Forensic Medicine (252 citations). M. E. Gore has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Roger A’Hern, Jonathan L. Moore, Timothy John Perren, Raymond Despax, G. Favalli, Giovanna Scarfone, Jaap Verweij, Wim W. ten Bokkel Huinink, Giorgio Bolis and Simon Van Belle. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.